Months after landing Canadian site from government, Resilience announces a big mRNA partner
Bob Nelsen’s latest project, dreamed up out of anger, has been focused on becoming the Amazon Web Services of drug manufacturing, with the ability to scale in the most efficient way possible. It has now partnered with one of the most influential players in the pandemic response.
Resilience will start making mRNA for Moderna’s Covid-19 vaccine at its new site in Canada, the company announced Wednesday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.